Gastrointestinal Cancer

Oncology·MeSH: Gastrointestinal Neoplasms

9 drugs in development·4 companies·18 clinical trials

Drug Pipeline by Phase

Phase 3(3)

Drug	Company
FOLFOX-4	IGM Biosciences, Inc. (IGMS)
FOLFOX-7	IGM Biosciences, Inc. (IGMS)
Tumor vaccine-induced specific T-cell injection	Crinetics Pharmaceuticals, Inc. (CRNX)

Phase 2(3)

Drug	Company
FOLFOX regimen	IGM Biosciences, Inc. (IGMS)
Leucovorin	Jazz Pharmaceuticals plc (JAZZ)
ompenaclid	IGM Biosciences, Inc. (IGMS)

Phase 1(2)

Drug	Company
arr-217	ArriVent BioPharma, Inc. (AVBP)
ARR-217 (MRG-007)	ArriVent BioPharma, Inc. (AVBP)

Phase 4(1)

Drug	Company
XH001 injection	Crinetics Pharmaceuticals, Inc. (CRNX)

BioSniper tracks 9 drugs in development for Gastrointestinal Cancer across 4 companies.

There are 18 clinical trials targeting Gastrointestinal Cancer tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.